<DOC>
	<DOCNO>NCT03033342</DOCNO>
	<brief_summary>A phase one study safety , tolerability , pharmacokinetics new oxazolidinone antibiotic . Cohorts healthy adult ( female male ) participate : single dose escalation study increase dos MRX-4 give mouth others participate multiple dose escalation cohorts MRX-4 give twice daily mouth . cohort subject participate study evaluate impact concomitant food Omeprazole safety , tolerability pharmacokinetics MRX-4</brief_summary>
	<brief_title>Single Dose Escalation Multiple Dose Escalation Trial Oral Formulation MRX-4</brief_title>
	<detailed_description />
	<mesh_term>Omeprazole</mesh_term>
	<criteria>Healthy subject Underlying hepatic , renal , metabolic , hematologic , cardiovascular , immunologic disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Phase 1</keyword>
</DOC>